Pharmacological inhibition of the NLRP3 inflammasome as a potential target for multiple sclerosis induced central neuropathic pain
Crossref DOI link: https://doi.org/10.1007/s10787-017-0401-9
Published Online: 2017-09-30
Published Print: 2018-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Khan, Nemat
Kuo, Andy
Brockman, David A.
Cooper, Matthew A.
Smith, Maree T.
Funding for this research was provided by:
National Health and Medical Research Council (APP1059239)
Australian Research Council (ARC) Linkage grant (LP120200623)
License valid from 2017-09-30